Clinical Trial Update: Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating reduced-intensity conditioning with fludarabine, busulfan, and thymoglobulin for hematopoietic stem cell transplantation in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: King's College Hospital NHS Trust | Conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | Phase 2 | Status: TERMINATED